United Kingdom news - the latest biotech news from Labiotech.eu

Home United Kingdom Page 76

Latest Posts

News and Trends 30 Jun 2015

Qiagen vs. Illumina, the next Big Fight in Next-gen Sequencing

Next-gen sequencing is a revolution. San Diego-based Illumina owns most of the market but German giant Qiagen is prepared to disrupt this fact by stepping in massively by the end of the year. The fight has only begun. Imagine you could sequence your genome to discover the disease you may have in the future. What if I told you, […]

June 30, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 28 Jun 2015

Google and big names helped Oxford Sciences Innovation to raise €457M

Oxford Sciences Innovation has completed the second close of its fundraising, raising an additional €157.3M (£110M) and bringing the total amount raised to €457.6M (£320M). This second close included some well-known investors such as Google Ventures and Charles Dunstone. Being backed by one of the best-recognized institutions in the world has its advantages. Oxford University […]

June 28, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Jun 2015

AstraZeneca’s senior managers are abandoning ship

In just a couple of weeks, AstraZeneca has seen two of its chiefs leave their position to run two smaller biotechs. James Ward-Lilley made his exist from Astra to become CEO of Vectura, just a few days after Briggs Morrison abruptly left to also become CEO of Syndax. The rich also cry, said the telenovela and […]

June 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Jun 2015

American Companies are Invading London’s Biotech Stock Market

[Update: On June 19, Puretech successfully raised $171M – approximately €150M – during its IPO, setting its market cap at €509M] Boston-based PureTech Health plans to raise €147M on the London stock market, following the path of Verseon, a San Diego-based bioinformatic company that raised €92M earlier this month. Is there a new American trend to earn cash in […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 17 Jun 2015

Innovate UK accelerates Sareum’s fight against Leukemia

Innovate UK, the country’s innovation agency, keeps promoting technology in the British islands. The latest beneficiary is Sareum, a cancer specialist biotech with a strong autoimmune disease programme. The company received €195.5k to fight an early-age type of leukaemia. T-Cell Acute Lymphoblastic Leukaemia is a rare type of leukaemia that most often occurs in late […]

June 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 15 Jun 2015

GSK’s undercover incubator baked three new Biotechs

The partnership between GlaxoSmithKline and Avalon Ventures launched three early-stage life science companies. Adrenergics, CadheRx Therapeutics and Calporta Therapeutics will each receive up to €8.9M in a Series A financing, aside from support from their two godfathers. Three new companies were launched today as a result of Avalon’s fruitful collaboration with GSK. The partnership, which […]

June 15, 2015 - 2 minutesmins - By Lourdes Riquelme

ADVERTISEMENT

News and Trends 12 Jun 2015

The first-in-human proof that Epigenetics marks are transmitted to the offspring

If a father works out every night and day at the gym, will he have a brawny baby? Well, yes and no. It might sound Lamarckian but the French naturalist might have had a point. A team of researchers from the University of Cambridge has described for the first time in humans how some regions […]

June 12, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 12 Jun 2015

MRC Technology and Peptinnovate partnered to cure bone diseases

MRC Technology and Peptinnovate teamed up to target bone diseases using peptides derived from the bacterium Mycobacterium tuberculosis. The partnership was created at Stevenage Bioscience Catalyst, a UK-based life sciences cluster. Natural peptides from M. tuberculosis, the pathogen that causes this feared disease, are able to modify the immunological and inflammatory response in humans. The bacteria employ […]

June 12, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 10 Jun 2015

A new ‘Fingerprinting’ Identification tool to unlock Algae potential

The world of Algae and Microalgae will be transformed thanks to the work of scientists of the Newcastle University and the Scottish Association for Marine Science. The same way people can be recognized by their fingerprints, the algae’s proteome is used as an identification to catalog them. Using this new approach instead of classical DNA markers and physical characteristics, researchers discovered […]

June 10, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 9 Jun 2015

Apitope’s peptide to take on Haemophilia A

Apitope’s pre-clinical candidate ATX-F8-117 has been granted Orphan Drug Status by the US FDA for the treatment of Haemophilia A. The drug candidate already obtained an Orphan Drug Designation by the European Medical Agency last year. The compound also awakened the interest of Abzena, which works with Apitope to design the candidate. Haemophilia A is […]

June 9, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 5 Jun 2015

NuCana’s potent anti-cancer completed Phase I/II

Good news just keeps on coming from ASCO Annual Meeting. Edinburgh-based NuCana presented in two abstracts the last data from Acelarin, the company’s first anti-cancer agent, produced on its ProTide developing platform. ProTides are NuCana’s new class of anti-cancer agents, which are specifically designed to overcome key cancer resistance mechanisms that severely limit the action […]

June 5, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 4 Jun 2015

[Update] AstraZeneca to buy a CAR-T expert?

[Update] Bloomberg announced that they make wrong conclusions from their discussion with AstraZeneca’s CEO Pascal Soriot. The CEO was not talking about the specific acquisition of Juno Therapeutics but about a potential acquisition of a CAR-T expert. Juno’s shares rose as much as 15.8 % just after the rumor was released by Bloomerg. Here is the first version […]

June 4, 2015 - 3 minutesmins - By Lourdes Riquelme

ADVERTISEMENT